Updated:
BLG Advisor
BOLD Longevity Growth is a leading global longevity fund investing in frontier biotechnologies to treat the root causes of disease and extend the healthy human...
Overview
BOLD Longevity Growth is a leading global longevity fund investing in frontier biotechnologies to treat the root causes of disease and extend the healthy human lifespan. The fund specializes in the growth and scaling stages at the intersection of longevity, biotech, and artificial intelligence with a mission to make those technologies affordable and accessible for everyone. It invests in platform technologies making over 5-10x improvements in efficiency and safety, targeting growth-stage companies focused on root causes of aging and diseases.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, United States
Principals
Sergey Young
Co-Founder
Teymour Boutros-Ghali
Co-Founder
Peter Diamandis
MD, Co-Founder
Avik Arakelian
Partner & Head of Investments
Kris Verburgh
MD, Partner & Head of Science
Sun Altbach
Senior Scientific Advisor
Gunner Hardy
Senior Associate
Sector focus
Frequently asked questions
What asset classes does BLG Advisor target?
The firm focuses on growth equity and venture investments.
Where is BLG Advisor headquartered?
The firm is based in Boston, United States.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: